Running with the obligation for information of material impact...

Running with the obligation for information of material impact on SP must be shared with the market, then no news is, in theory, good news (albeit frustrating). Logically, nothing has changed except CR to apparently to fast track human trials (more info on this soon i hope) and we know U-vet has been engaged for some weeks plus the number of patients has expanded. The U-vet is still seeking participants according to their website.

https://www.u-vet.com.au/news/new-treatment-for-dogs-with-lymphoma-seeking-participants-for-clinical-trial

Most importantly, the fundamentals have not been disproven so it is a game of nerves while the rigor of science sets its course. Looking forward to the info from the AGM and answers to the questions posed on the other thread or at least getting some degree of clarity....... So otherwise, just strapping in for a bit of a ride by the look of things - for a few days at least.

Good luck all and look forward to updates from the AGM although not quite sure what they will put out there without notification to the market concurrently if that info is material & they know prior.